Noninvasive and Transient Blood-Brain Barrier Opening in the Hippocampus of Alzheimer's Double Transgenic Mice Using Focused Ultrasound

Abstract

The spatio-temporal nature of focused ultrasound-induced blood-brain barrier (BBB) opening as a brain drug delivery method was investigated in Alzheimer's disease model mice. The left hippocampus of transgenic (APP/PS1, n = 3) and nontransgenic (n = 3) mice was sonicated (frequency: 1.525 MHz, peak-negative pressure: 600 kPa, pulse length: 20 ms, duty cycle: 20%, duration: 1 min) in vivo, through their intact skin and skull, after intravenous injection of microbubbles (SonoVue®5; 25 μl). Sequential, high-field MR images (9.4 Tesla) were acquired before and after injection of gadolinium (Omniscan™ 0.75 ml, molecular weight: 573.7 Da) on two separate days for each mouse. Gadolinium deposits through the ultrasound-induced BBB opening in the left hippocampus revealed significant contrast-enhancement in the MRI. On the following day, MRI revealed significant BBB closure within the same region. However, the BBB opening extent and BBB closing timeline varied in different regions within the same sonicated location. This indicates that opening and closing were dependent on the brain region targeted. No significant difference in BBB opening or closing behaviors was observed between the APP/PS1 and the nontransgenic mice. In conclusion, a BBB-impermeable molecule was noninvasively, transiently and reproducibly delivered to the hippocampus of Alzheimer's APP/PS1 mice.

Keywords

Alzheimer disease blood-brain barrier drug delivery system magnetic resonance imaging ultrasonic therapy

Get full access to this article

View all access options for this article.

References

Wimo

Winblad

Aguero-Torres

von Strauss

. The magnitude of dementia occurrence in the world, Alzheimer Disease Assoc Disorders 17, 63–7 (2003).

Hull

Berger

Heneka

. Disease-modifying therapies in Alzheimer's disease: how far have we come?, Drugs 66, 2075–2093 (2006).

Areosa

Sherriff

McShane

. Memantine for dementia, Cochrane Database Systematic Rev (Online) CD003154 (2005).

Birks

Harvey

. Donepezil for dementia due to Alzheimer's disease, Cochrane Database Systematic Rev (Online) CD001190 (2006).

Pardridge

. The blood-brain barrier: bottleneck in brain drug development, NeuroRx 2, 3–14 (2005).

Hills

Vacca

. Progress toward a practical BACE-1 inhibitor, Current Opinion Drug Discovery Develop 10, 383–391 (2007).

Barten

Meredith

Jr. Zaczek

Houston

Albright

. Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity, Drugs R & D 7, 87–97 (2006).

Stewart

Tuor

. Blood-eye barriers in the rat: correlation of ultrastructure with function, J Comp Neurol 340, 566–576 (1994).

Pardridge

. Drug targeting to the brain, Pharma Res 24, 1733–1744 (2007).

10.

Hynynen

McDannold

Vykhodtseva

Jolesz

. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits, Radiology 220, 640–646 (2001).

11.

Reinhard

Hetzel

Kruger

. Blood-brain barrier disruption by low-frequency ultrasound, Stroke 37, 1546–1548 (2006).

12.

McDannold

Vykhodtseva

Hynynen

. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity, Phys Med Biol 51, 793–807 (2006).

13.

Kinoshita

McDannold

Jolesz

Hynynen

. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption, Proc Natl Acad Sci 103, 11719–11723 (2006).

14.

Choi

Pernot

Small

Konofagou

. Feasibility of transcranial, localized drug-delivery in the brain of Alzheimer's-model mice using focused ultrasound, in Proc IEEE Ultrason Symp, pp. 988–999 (IEEE, 2005).

15.

Choi

Pernot

Small

Konofagou

. Noninvasive Blood-Brain Barrier Opening in Live Mice, AIP Proc 829, 271–275 (2006).

16.

Choi

Small

Konofagou

. Optimization of blood-brain barrier opening in mice using focused ultrasound, in Proc IEEE Ultrason Symp, pp. 540–543 (IEEE, 2006).

17.

Choi

Pernot

Brown

Small

Konofagou

. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound, Phys Med Biol 52, 5509–5530 (2007).

18.

Choi

Pernot

Small

Konofagou

. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice, Ultrasound Med Biol 33, 95–104 (2007).

19.

Raymond

Skoch

Hynynen

Bacskai

. Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo, J Cereb Flow Metab 27, 393–403 (2007).

20.

Treat

McDannold

Vykhodtseva

. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound, Int J J Cancer 121, 901–907 (2007).

21.

Choi

Wang

Morrison

III Konofagou

. Molecular delivery and microbubble dependence study of the FUS-induced blood-brain barrier opening in vivo, in Proc IEEE Ultrason Symp, pp. 1192–1195 (IEEE, 2007).

22.

Hsiao

Chapman

Nilsen

. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science 274, 99–102 (1996).

23.

Duff

Eckman

Zehr

. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1, Nature 383, 710–713 (1996).

24.

McGowan

Sanders

Iwatsubo

. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes, Neurobiol Disease 6, 231–244 (1999).

25.

Ford

Wood

Van

Winkle TJ

Kundel

. Magnetic resonance imaging observations of blood-brain-barrier permeability in an animal model of brain injury, Acad Radiol 4, 115–126 (1997).

26.

Moreno

Hua

Brown

Small

. Longitudinal mapping of mouse cerebral blood volume with MRI, NMR Biomed 19, 535–43 (2006).

27.

Dorr

Sled

Kabani

. Three-dimensional cerebral vasculature of the CBA mouse brain: a magnetic resonance imaging and micro computed tomography study, Neurolmage 35, 1409–1423 (2007).

28.

Jain

Kamal

Batra

. Engineering antibodies for clinical applications, Trends Biotech 25, 307–316 (2007).

29.

Algotsson

Winblad

. The integrity of the blood-brain barrier in Alzheimer's disease, Acta Neurol Scand 115, 403–8 (2007).

30.

Konofagou

Choi

. Ultrasound-induced treatment of neurodegenerative diseases across the blood-brain barrier, in Biomedical Applications of Vibration and Acoustics in Therapy, Bioeffects and Modelling, Al-Jumaily

Fatemi

, Eds., pp. 63–80 (ASME Press, 2008).